Management of Face Flushing with Systemic Corticosteroids

Understanding the Mechanism

Facial flushing is a documented side effect of systemic corticosteroids, particularly with intravenous methylprednisolone administration, occurring due to vasodilation triggered by the medication 1
This condition is distinct from other steroid-related facial changes like moon facies, which develops over weeks to months with chronic use 2

No intervention is typically required for facial flushing from steroids, as it is transient and self-resolving, usually lasting minutes to hours after administration 1
The American College of Physicians recommends continuing the steroid therapy if clinically indicated, as flushing alone does not warrant discontinuation 3
Provide patient reassurance that this is an expected, benign side effect 1
Isolated flushing without other symptoms indicates a benign reaction, whereas flushing accompanied by respiratory symptoms, blood pressure changes, or skin eruptions suggests a Grade 1-2 infusion reaction requiring slowing or stopping the infusion 3
Severe reactions with hypotension, bronchospasm, or anaphylaxis require immediate discontinuation and aggressive symptomatic treatment 3

Cosmetic changes including facial rounding, hirsutism, and striae occur in 80% of patients after two years of therapy at doses >10 mg daily, according to the British Association of Dermatologists 2
These changes are dose and duration-dependent, with significant risk at doses exceeding 10 mg daily for more than 18 months 2
Consider steroid-sparing agents when long-term therapy is anticipated to minimize these cosmetic complications, as recommended by the British Association of Dermatologists 4, 2

Monitor blood pressure and blood glucose regularly, as hypertension and glucose intolerance commonly accompany steroid therapy, according to the American Academy of Dermatology 5, 2
Perform regular ophthalmologic examinations to screen for cataracts and glaucoma 5, 2
Assess bone mineral density for patients on long-term therapy (>3 months) 2

Use the lowest effective dose for the shortest duration possible to minimize all steroid-related side effects, including facial flushing and cosmetic changes, as recommended by the American Academy of Dermatology 5, 2
Taper prednisone to <10 mg daily as quickly as clinically feasible, as doses above this threshold significantly increase adverse effects 2
Limit treatment courses to 6-8 weeks unless absolutely necessary for disease control 2
Consider alternate-day therapy when appropriate to reduce cumulative steroid exposure 2

Do not discontinue steroids abruptly due to flushing alone, as this risks adrenal insufficiency and disease flare, according to the American Academy of Dermatology 5